Koya Medical to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
CEO Andy Doraiswamy highlights the company’s growth and commercial momentum for its portfolio—including Dayspring®
News
Multi-Society Endorsed Position Statement Affirms the Clinical Value of Non-Pneumatic Compression in Lymphedema Management
NPCD endorsed by the American Venous Forum and the American Venous and Lymphatic Society as an effective option for lymphedema management.
Liberate Medical Completes Enrollment of 250-Patient PREVENT Pivotal Trial Evaluating VentFree® Respiratory Muscle Stimulator
First-in-Class Non-Invasive Ventilator Weaning Technology Fully Enrolled in Global Randomized Controlled Trial; Public Results Presentation Planned for late 2026 CRESTWOOD, KY, March 3, 2026 — Liberate Medical, a clinical-stage medical device company developing breakthrough neuromuscular electric
Koya Medical to Present at the J.P. Morgan 2026 Healthcare Conference
Koya CEO Andy Doraiswamy will highlight the company’s growth and commercial momentum for its portfolio—including Dayspring®.
Koya Medical to Present at the J.P. Morgan 2026 Healthcare Conference Read More »
Using Ultrasound Stimulation to Reduce Inflammation in COVID-19 In-Patients
Researchers at UC San Diego School of Medicine have begun a pilot clinical trial to test the efficacy of using ultrasound to stimulate the spleen and reduce COVID-19-related inflammation, decreasing the length of hospital stays.
Using Ultrasound Stimulation to Reduce Inflammation in COVID-19 In-Patients Read More »
